Stem Cell Advance Brings Vision Repair in Sight
STEMAXON has been nominated as a finalist for the ADRIQ's ''26th INNOVATION AWARD''
In the News:
FOLLOW US ON LINKEDIN
MEMBER OF BIOQUÉBEC
Stem Cells: Regeneration Methods for the Visual System
La biología y el tratamiento de la ceguera con células madre
The Biology of Treating Blindness with Stem Cells
El trasplante de fotorreceptores llega para curar la degeneración macular
STEMAXON is a Canadian biotechnology company located in the Greater Montréal Area which specializes in stem cell technology.
Des cellulles souches pour soigner la vision
STEMAXON to validate the technology of iPSC differentiation into photoreceptor cells for cell therapy applications
Restoring vision with stem cells
STEMAXON's cumulative IP, starting with the only proven human sporadic AD model (patent pending) and AD-cascade related compounds (patent pending) greatly advance drug development and testing in the treatment and early stage diagnostics of Alzheimer’ disease.
STEMAXON's Legal partners are Fasken Martineau.